Imiquimod-induced ROS production causes lysosomal membrane permeabilization and activates caspase-8-mediated apoptosis in skin cancer cells. Issue 3 (September 2022)
- Record Type:
- Journal Article
- Title:
- Imiquimod-induced ROS production causes lysosomal membrane permeabilization and activates caspase-8-mediated apoptosis in skin cancer cells. Issue 3 (September 2022)
- Main Title:
- Imiquimod-induced ROS production causes lysosomal membrane permeabilization and activates caspase-8-mediated apoptosis in skin cancer cells
- Authors:
- Chang, Shu-Hao
Lin, Pei-Ying
Wu, Tsai-Kun
Hsu, Chien-Sheng
Huang, Shi-Wei
Li, Zheng-Yi
Liu, Kuang-Ting
Kao, Jun-Kai
Chen, Yi-Ju
Wong, Tak-Wah
Wu, Chun-Ying
Shieh, Jeng-Jer - Abstract:
- Abstract: Background: Lysosomal cell death is induced by lysosomal membrane permeabilization (LMP) and the subsequent release of lysosomal proteolytic enzymes, including cathepsins (CTSs), which results in mitochondrial dysfunction and apoptosis. Imiquimod (IMQ), a synthetic TLR7 ligand, has both antiviral and antitumor activity against various skin malignancies in clinical treatment. Previously, we demonstrated IMQ not only caused lysosomal dysfunction but also triggered lysosome biogenesis to achieve lysosomal adaptation in cancer cells. Objective: To determine whether lysosomes are involved in IMQ-induced apoptosis. Methods: The human skin cancer cell lines BCC, A375 and mouse melanoma cell line B16F10 were used in all experiments. Cell death was determined by the Cell Counting Kit-8 (CCK-8) assay and DNA content assay. Protein expression was determined by immunoblotting. Caspase-8 activity was assessed using a fluorescence caspase-8 kit and determined by flow cytometry and confocal microscopy. Results: IMQ not only induced lysosome damage but also abrogated lysosome function in skin cancer cells. IMQ-induced caspase-8 activation contributed to the processes of lysosomal cell death. Moreover, the use of ROS scavengers significantly abolished caspase-8 activation and inhibited IMQ-induced LMP. Additionally, pharmacological inhibition of CTSD not only abrogated caspase-8 activation but also rescued IMQ-induced cell death. Finally, lysosome-alkalizing agents enhanced theAbstract: Background: Lysosomal cell death is induced by lysosomal membrane permeabilization (LMP) and the subsequent release of lysosomal proteolytic enzymes, including cathepsins (CTSs), which results in mitochondrial dysfunction and apoptosis. Imiquimod (IMQ), a synthetic TLR7 ligand, has both antiviral and antitumor activity against various skin malignancies in clinical treatment. Previously, we demonstrated IMQ not only caused lysosomal dysfunction but also triggered lysosome biogenesis to achieve lysosomal adaptation in cancer cells. Objective: To determine whether lysosomes are involved in IMQ-induced apoptosis. Methods: The human skin cancer cell lines BCC, A375 and mouse melanoma cell line B16F10 were used in all experiments. Cell death was determined by the Cell Counting Kit-8 (CCK-8) assay and DNA content assay. Protein expression was determined by immunoblotting. Caspase-8 activity was assessed using a fluorescence caspase-8 kit and determined by flow cytometry and confocal microscopy. Results: IMQ not only induced lysosome damage but also abrogated lysosome function in skin cancer cells. IMQ-induced caspase-8 activation contributed to the processes of lysosomal cell death. Moreover, the use of ROS scavengers significantly abolished caspase-8 activation and inhibited IMQ-induced LMP. Additionally, pharmacological inhibition of CTSD not only abrogated caspase-8 activation but also rescued IMQ-induced cell death. Finally, lysosome-alkalizing agents enhanced the cytotoxicity of IMQ in vitro and in vivo. Conclusions: IMQ-induced ROS accumulation promotes LMP, releases CTSs into the cytosol, stimulates caspase-8 activation and finally causes lysosomal cell death. Lysosomal cell death and the CTSD/caspase-8 axis may play a crucial role in IMQ-induced cell death. Highlights: IMQ causes lysosomal membrane permeabilization and CTSs releasing into cytosol in skin cancer cells. IMQ induces lysosomal cell death which is mediated by CTSD/caspase-8 axis. IMQ-induced ROS generation is crucial for IMQ-induced caspase-8 activation and lysosomal cell death. Combination treatment with lysosome-alkalinizing agents and IMQ enhances anti-tumor response in skin cancer cells. … (more)
- Is Part Of:
- Journal of dermatological science. Volume 107:Issue 3(2022)
- Journal:
- Journal of dermatological science
- Issue:
- Volume 107:Issue 3(2022)
- Issue Display:
- Volume 107, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 107
- Issue:
- 3
- Issue Sort Value:
- 2022-0107-0003-0000
- Page Start:
- 142
- Page End:
- 150
- Publication Date:
- 2022-09
- Subjects:
- Imiquimod -- Lysosomal cell death -- ROS
Dermatology -- Periodicals
Skin Diseases -- Periodicals
Dermatologie -- Périodiques
616.5005 - Journal URLs:
- http://www.elsevier.com/journals ↗
http://www.sciencedirect.com/science/journal/09231811 ↗ - DOI:
- 10.1016/j.jdermsci.2022.08.006 ↗
- Languages:
- English
- ISSNs:
- 0923-1811
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4968.766500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23987.xml